Scientists at the Salk Institute are buoyed after a first-of-its-kind study provided further clues on how plants in later stages of life protect themselves from environmental threats. Their findings ...
A team of Chinese scientists has used targeted gene editing to develop rice that produces coenzyme Q10 (CoQ10), a vital ...
Two biotechs say they’re using AI to conjure drugs from scratch. Their documents suggest otherwise
A STAT examination shows how AI-powered biotechs like Absci and Generate Biomedicines routinely aggrandize their AI ...
Latent Labs has raised $50 million of new funding as it commercialises its GenAI technology for designing new proteins for ...
These drugs, discovered decades ago, continue to save lives today, but more recent research has led to the development of ...
Antimicrobial resistance (AMR) presents a significant challenge to global health, necessitating innovative therapeutic ...
The cuts at two Massachusetts plants follow further site closures and layoffs across the company over the past few years.
The Tax Cuts and Jobs Act of 2017 reconfigured the tax code. Did it also enable a pharmaceutical giant to invest in Wake County? Or did it simply increase their profits?
Trinity Biotech (Nasdaq:TRIB) announced new pre-pivotal clinical ... Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery ...
The company started the first phrase of its operation in the city in January at the David Lust Accelerator Building on the Elevate Rapid City campus.
Fields is now on a drug approved by the Food and Drug Administration named Enhertu, developed and commercialized by biotech giants AstraZeneca and Daiichi Sankyo. Enhertu is not specifically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results